According to NHS estimates, hypothyroidism affects approximately 1-2% of the UK population, with a significantly higher prevalence in women
The dosing structures are different, the concentrations from compounding pharmacies are different, and the clinical outcomes are different
Alcohols influence on blood sugar, combined with semaglutides effects, can lead to unpredictable outcomes
Many of them have been used in weight-loss teas, pills, and powders for decades, in some cases even longer than GLP-1 medications, yet they have never caused a true breakthrough in weight-loss treatment
This segment matters most in the near term, though step-down users and broader weight-management consumers are likely to widen the addressable market over time
These medications slow gastric emptying, reduce cravings, and improve insulin sensitivityhelping patients achieve steady, effective weight loss without extreme dieting